Watch Ticker

Xencor, Inc.

Go to Xencor, Inc. Website

$7.95

0.00 (0.00%)

Live

Previous Close

$7.95

Day Range

$7.73 - $8.21

Previous Day Range

$7.68 - $8.165

Market Cap

$565.8 million USD

Day Vol.

672036

Previous Day Vol.

595241

Currency

USD

Primary Exchange

Nasdaq

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody produ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Custom Market Insights - [Latest] Global Ultomiris Drug Market Size/Share Worth USD 64.12 Billion by 2034 at a 31.52% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

The global Ultomiris drug market is expected to grow from USD 4.16 Billion in 2024 to USD 64.12 Billion by 2034, with a robust 31.52% CAGR, driven by increasing demand for long-acting treatments for rare disorders like PNH and gMG.

Related tickers: AZN, XNCR, ARGX.

Read Full Article

Zacks - Xencor Surges 10.5%: Is This an Indication of Further Gains?

Xencor shares surged 10.5% after the company announced a secondary stock offering to raise $175 million. The company plans to use the funds to support its pipeline development. However, earnings and revenue expectations for the upcoming quarter are negative, which may impact the stock's future performance.

Related tickers: XNCR, USNA.

Read Full Article

Trending Tickers

Please sign in to view